Skip to main content

Agilent, Gachon University Collaborate on Proteomics, Glycoproteomics Biomarker Research

NEW YORK (GenomeWeb News) – Agilent Technologies today announced a collaboration with Gachon University of Medicine and Science in South Korea to use proteomics and glycoproteomics for biomarker discovery.

Under a memorandum of understanding, the laboratory at the university's College of Pharmacy will serve as Agilent's beta test site for complete glycoproteomics and biomarker discovery workflow solutions.

Agilent did not say what disease areas the research will be directed toward but said Gachon's College of Pharmacy is renowned for research into the prevention and treatment of cancer and diabetes.

Financial and other terms of the deal were not disclosed.

"Glycoproteomics is a key focal point in various aspects of life sciences research," Rod Minett, general manager of Agilent's life sciences business in South Korea and the South Asia Pacific region, said in a statement. "Through this collaboration, we hope to help scientists and researchers advance their research, unlock the genetic causes of disease and accelerate the discovery and development of new drugs."

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.